IGF1 and pulmonary hypertension: Moreover, in the pathophysiology of pulmonary hypertension, hypoxic condition will enhance the IGF-1 secretion from the arterial smooth muscle cells, by which to affect pulmonary vessel remodeling (Sun et al., 2016).